Major shareholder of Chongqing Pharscin Pharmaceutical (002907.SZ) plans to reduce their shareholding by no more than 3%

Chongqing Pharscin Pharmaceutical (002907.SZ) announced that the company recently received a notice from Mr. You Hongtao, a controlling shareholder acting in concert, and Shanghai Tiancheng Investment Management Co., Ltd. - Tiancheng Tianli No. 1 Private Equity Securities Investment Fund (referred to as "Tiancheng Tianli No. 1 Fund"), regarding their plan to reduce their holdings of the company's shares. The total reduction plan will not exceed 12.5278 million shares, which is not more than 3% of the company's total share capital.